Late-Breaking KidneyIntelX Evidence Released at 83rd American Diabetes Association…
12 Months KidneyIntelX™ in vitro prognostic testing continued to demonstrate clinical actions that lead to improvement in both diabetes (A1C reductions) and kidney health (eGFR slope…